Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
8.82
+0.44 (5.25%)
At close: May 12, 2025, 4:00 PM
8.82
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $310.96 million as of May 12, 2025. Its market cap has decreased by -22.81% in one year.
Market Cap
310.96M
Enterprise Value
-13.14M
1-Year Change
-22.81%
Ranking
Category
Stock Price
$8.82
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $310.96M, an increase of 23.88%. That is a compound annual growth rate of 6.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 295.45M | -51.74% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |